Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;56(7):1996-2000.
doi: 10.1007/s10620-011-1680-4. Epub 2011 Apr 6.

Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation

Benjamin J Vaccaro  1 , Susana Gonzalez, John M Poneros, Peter D Stevens, Kristina M Capiak, Charles J Lightdale, Julian A Abrams
Affiliations

Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation

Benjamin J Vaccaro et al. Dig Dis Sci. 2011 Jul.

Abstract

Background: Radiofrequency ablation (RFA) is an effective means of eradicating Barrett's esophagus (BE), both with and without associated dysplasia. Several studies have documented high initial success rates with RFA. However, there is limited data on IM detection rates after eradication.

Aims: To determine the rate of detection of intestinal metaplasia (IM) after successful eradication of Barrett's esophagus.

Methods: BE patients with and without dysplasia who had undergone RFA were retrospectively identified. Only those who had complete eradication as documented on the initial post-ablation endoscopy, and had minimum two surveillance endoscopies, were included in the analyses. Clinical, demographic, and endoscopic data were collected. Cumulative incidence of IM detection was calculated by the Kaplan-Meier method.

Results: Forty-seven patients underwent RFA and had complete eradication of Barrett's epithelium. The majority of patients were male (76.6%), and the mean age was 64.2 years. The cumulative incidence of newly detected IM at 1 year was 25.9% (95% CI 15.1-42.1%). Dysplasia was detected at the time of recurrence in four patients, and all cases were detected at the GE junction in the absence of visible BE. Patients with recurrent IM had longer baseline segments of BE (median, 4 cm vs. 2 cm, p = 0.03).

Conclusions: The rate of detection of new IM is high in patients who have undergone successful eradication of BE by RFA. Additionally, dysplasia can recur at the GE junction in the absence of visible BE. Future studies are warranted to identify those patients at increased risk for the development of recurrent intestinal metaplasia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cumulative incidence of intestinal metaplasia in patients who had undergone radiofrequency ablation for Barrett's esophagus with complete eradication
See this image and copyright information in PMC

References

    1. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831. - PubMed
    1. Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23:451–457. - PMC - PubMed
    1. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125:1670–1677. - PubMed
    1. Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet. 2009;373:850–861. - PubMed
    1. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2006;4:566–572. - PubMed

Publication types